Matrix Interactions Pertinent to High IOP and Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
G2006011
Goals
This study will evaluate the effect of altering trabecular meshwork components on TM function and regulation of intraocular pressure.
Summary
Elevated intraocular pressure (IOP) is a major risk factor for glaucoma and results from alteration of the pathway that drains aqueous humor from the anterior eye. While studies have been performed to characterize this pathway in human and non-human primate tissues, our understanding of its organization is still very limited. The outflow pathway is comprised, in part, of a region known as the trabecular meshwork (TM). The TM is a series of cells and connective tissues organized as a filter. Alterations in several TM components have been correlated with elevated IOP. We have identified a new component in the TM that we hypothesize will stabilize this region and help to regulate normal IOP. We will examine the TM in the mouse to evaluate the organization of this and other components thought to regulate IOP. We will then exploit the genetic capabilities of the mouse and examine mutants that have altered expression of key TM regulatory components. We will evaluate the effect these alterations have on TM function and IOP regulation. Given the similarities between the components in mouse and human TM tissues, our findings will likely be highly relevant to human IOP regulation and thus may lead to intervention strategies for the future.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute